New Rome-IV criteria of the functional dyspepsia (review)
https://doi.org/10.22416/1382-4376-2016-4-124-128
Abstract
Aim of review. To analyze the changes in the IV revision of Rome criteria of the functional dyspepsia (FD) in comparison to existing criteria. Key points. The definition of FD and its main variants - postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS) in new criteria did not undergo major changes in comparison to previous edition. Frequent combination of PDS and EPS both with each other, with such symptoms as nausea and belching and some other diseases as gastroesophageal reflux disease and irritable bowel syndrome was demonstrated. It is, still, recommended to make the diagnosis of FD, being guided both by compliance of patients symptoms to Rome criteria and the absence of alarm symptoms. The major place in the treatment of PDS is occupied by prokinetics, in EPS treatment - by antisecretory medications. Conclusion. The fourth revision of Rome criteria of FD have certain advantages in comparison to the previous criteria, but at the same time preserve essential shortcomings.
About the Authors
A. A. Sheptulin
State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»
Russian Federation
Russian Federation
A. A. Kurbatova
State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university»
Russian Federation
Russian Federation
References
1. Ивашкин В.Т., Шептулин А.А., Лапина Т.Л. и др. Диагностика и лечение функциональной диспепсии. Методические рекомендации Российской гастроэнтерологической ассоциации для врачей. М., 2011. 28 с.
2. Drossman D.A., Hasler W.L. Rome IV Functional GI disorders: disorders of gut-brain interaction. Gastroenterology 2016; 150(6):1257-61.
3. Holtmann G., Nandurkar S., Talley N.J., et al. Herbal medicine for the treatment of functional dyspepsia: a systematic review of the literature and meta-analysis. Gastroenterology 2007; suppl. 2. Abstract W1204.
4. Houghton L.A., Heitkemper M., Crowell M.D., et al. Age, gender and women’s health and patient. Gastroenterology 2016; 150(6):1332-43.
5. Madisch A., Holtmann G., Plein K., Hotz J. Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial. Aliment Pharmacol Ther 2004; 19:271-9.
6. Ottilinger B., Storr M., Malfertheiner P., Allescher H.-D. STW 5 (Iberogast®) - a safe and effective standart in the treatment of functional gastrointestinal disorders. Wien Med Wochenschr 2013; 163:65-72.
7. Stanghellini V., Chan F.C.L., Hasler W.L., et al. Gastroduodenal disorders. Gastroenterology 2016; 150(6):1380-92.
8. Sugano K., Tack J., Kuipers E.J., et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut 2015; 64:133-67.
9. Tack J., Talley N.J., Camilleri M., et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130:1466-79.
10. Talley N.J. Dyspepsia: How to sort out the mess? Dig Dis Week, San Diego, 2016. Oral presentation.
11. Talley N.J. Functional ghastroduodenal disorders // AGA Institute-Rome Foundation lectureship: the launching of Rome IV: what’s new and why? Dig Dis Week, San Diego, 2016. Oral presentation.
12. Talley N.J., Locke G.R., Saito Y.A., et al. Effect of amitriptyline and escitalopram on functional dyspepsia: a multicenter, randomized controlled study. Gastroenterology 2015; 149:340-9.
Review
For citations:
Sheptulin A.A., Kurbatova A.A. New Rome-IV criteria of the functional dyspepsia (review). Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;26(4):124-128. (In Russ.) https://doi.org/10.22416/1382-4376-2016-4-124-128
Views:
9620
Email this article 
